Ameritas Investment Partners, Inc. Charles River Laboratories International, Inc. Transaction History

Ameritas Investment Partners, Inc.

$3.05 Billion
Q2 2025

A detailed history of Ameritas Investment Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,939 shares of CRL stock, worth $889,365. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,939

Previous 5,000 1.22%

Holding current value

$889,365

Previous $752,000 0.4%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$99.75 - $151.89 $6,084 - $9,265	-61 Reduced 1.22%	4,939 $749,000
Q4 2024 Feb 13, 2025	SELL	$178.58 - $220.69 $8,036 - $9,931	-45 Reduced 0.89%	5,000 $923,000
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $12,174 - $17,674	-74 Reduced 1.45%	5,045 $1.19 Million
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $340,014 - $431,370	1,725 Added 50.82%	5,119 $1.11 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $14,308 - $20,278	-56 Reduced 1.62%	3,394 $963,000
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $3,162 - $4,038	-9 Reduced 0.26%	3,450 $1.3 Million
Q2 2021 Aug 06, 2021	SELL	$294.17 - $371.65 $4.52 Million - $5.71 Million	-15,370 Reduced 81.63%	3,459 $1.28 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $23,468 - $28,151	-94 Reduced 0.5%	18,829 $5.25 Million
Q4 2020 Feb 12, 2021	SELL	$222.0 - $252.62 $70,152 - $79,827	-316 Reduced 1.64%	18,923 $4.73 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $382,194 - $492,981	-2,177 Reduced 10.17%	19,239 $4.36 Million
Q2 2020 Aug 05, 2020	BUY	$118.84 - $189.72 $61,915 - $98,844	521 Added 2.49%	21,416 $3.73 Million
Q4 2019 Feb 13, 2020	SELL	$126.05 - $152.76 $327,730 - $397,176	-2,600 Reduced 11.07%	20,895 $3.19 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $53,154 - $61,059	-425 Reduced 1.78%	23,495 $3.11 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $12,957 - $15,597	105 Added 0.44%	23,920 $3.39 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $392,385 - $470,890	3,500 Added 17.23%	23,815 $3.2 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $190,586 - $223,603	-1,941 Reduced 8.72%	20,315 $2.17 Million
Q3 2017 Nov 15, 2017	BUY	$96.72 - $109.26 $773,760 - $874,080	8,000 Added 56.12%	22,256 $2.42 Million
Q2 2017 Aug 15, 2017	BUY	N/A	14,256	14,256 $1.44 Million

Others Institutions Holding CRL

# of Institutions

635

Shares Held

52.8M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.16B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Account

Ameritas Investment Partners, Inc. Charles River Laboratories International, Inc. Transaction History